•
Mar 31, 2022

Harrow Q1 2022 Earnings Report

Announced record financial results for the seventh consecutive quarter.

Key Takeaways

Harrow Health reported a strong start to 2022, marking its seventh consecutive quarter of record financial results. The company saw a 43% increase in year-over-year revenues and a nearly 10% increase from the sequential quarter.

Achieved seventh consecutive quarter of record financial results.

Experienced a 43% increase in year-over-year revenues.

Saw a nearly 10% increase from the sequential quarter.

Anticipates potential commercial launch of AMP-100 in the first half of 2023, pending FDA approval.

Total Revenue
$22.1M
Previous year: $15.4M
+43.2%
EPS
$0.03
Previous year: $0.01
+200.0%
Gross Profit
$16.2M
Previous year: $11.7M
+38.4%
Cash and Equivalents
$41.9M
Previous year: $6.3M
+565.4%
Free Cash Flow
$563K
Previous year: $3M
-81.2%
Total Assets
$97.6M
Previous year: $56.3M
+73.5%

Harrow

Harrow

Forward Guidance

Harrow Health is confident in its future growth plan, aiming to build a profitable business and serve customers with its products and services.